Tim Enns is a seasoned biotechnology executive with over 30 years of experience in pharmaceutical sales, marketing, business development, investor relations, and partnering. He has a track record of successfully building and growing developmental and commercial biotech companies by identifying and managing scientific stories for dynamic teams to create and implement strategic initiatives, achieve objectives, and drive results.

Throughout his career, Enns has improved sales, expanded markets, launched drugs, developed partnerships, and secured investors and analysts to improve corporate value. He is currently the President and CEO of NanoValent Pharmaceuticals, Inc. and has held executive positions at KineMed, Astex Pharmaceuticals, Sequus, Ascalon, Transplant Therapeutics, Syncor International, MGI Pharma, Adria Laboratories, and The Upjohn Company.

Enns is a graduate of Stanford University Graduate School of Business, where he studied Certificate of Business Administration, Business, University of California, Davis, where he earned a BS in Nutritional Science, and West Valley College, where he earned an AA in Chemistry.